ALBHF Alibaba Health Info Tech

Alibaba Health Information Technology Limited, an investment holding company, engages in the pharmaceutical e-commerce, intelligent medicine, and product tracking platform businesses in the People's Republic of China. It engages in business-to-customer (B2C) retail activities; advertisement business; and business-to-business (B2B) centralized procurement distribution business. The company also provides pharmaceutical and healthcare products through its online stores on and offline pharmacy outlets to B2C and B2B customers; marketing services; health consultation services; outsourced and value-added services to the Tmall entities; and telemedicine services. In addition, it trades in pharmaceutical products; and provides network hospital services. The company was formerly known as CITIC 21CN Company Limited and changed its name to Alibaba Health Information Technology Limited in September 2014. The company is based in Causeway Bay, Hong Kong. Alibaba Health Information Technology Limited is a subsidiary of Perfect Advance Holding Limited.

Note: This is not a U.S. company, but they cross-list their shares on the U.S. over-the-counter market - see the related symbol HK:0241.

$0.94    Pink
As of 11/26/2021     OTCMarkets

Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Large cap
GICS sector:  Health Care
Industry:  Pharmaceutical Retailers
Index country:  China
Country of incorporation:  
IPO date:  11/30/2018
Outstanding shares:  13,489,820,000
Average volume:  18,134
Market cap:   $14,028,063,818
Current dividend yield:  0.00%
Valuation   (See tab for details)
PE ratio:   -131.15
PB ratio:   1.00
PS ratio:   5.74
Return on equity:   -0.75%
Net income %:   -4.38%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy